Anodontia
Conditions
Interventions
This is a double-blind, randomized, controlled, two-arm clinical study. Patients included in the research will undergo single dental implants. Patients will be divided in a ramdomized manner (www.rand
E02.594.540
Sponsors
Pontifícia Universidade Católica de Campinas
Pontifícia Universidade Católica de Campinas
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients over 18 years of age with an indication for dental implants will be included in the study according to the following inclusion criteria: Patients with an indication for upper (maxilla) and/or lower (mandible) single dental implants in healed sockets (at least 60 days after extraction); Healthy oral mucosa. A prior clinical analysis will be carried out and the patient must present no mucosal disease, that is, no phlogistic (inflammatory) and infectious signs; Patients who agree to participate in the research by signing the Informed Consent Form
Exclusion criteria
Exclusion criteria: Patients with systemic diseases, such as: diabetes mellitus, cardiovascular diseases, coagulation disorders, osteoporosis and/or hypertension; Patient undergoing radiation to the head or neck; Patients with a history of implant loss; Pregnant or lactating women; Sensitivity to light (photophobia); Smokers and alcohol addicts; Patients using medications that alter bone metabolism, such as: heparin, warfarin, cyclosporine, glucocorticoids, medroxyprogesterone acetate, oncological medications, thyroid hormone, prednisone, prednisolone, methylprednisolone, dexamethasone, cortisone and triamcinolone; Patients who have been or are being treated with antibiotics or anti-inflammatories for less than 2 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Verify reduction in postoperative pain in patients undergoing single dental implants in healed sockets through local and systemic photobiomodulation (PBM-T) using the VAS scale. The questionnaire administrator will be blind in relation to the sample groups and external to the research. The VAS scale consists of a score from 0 to 10, where 0 indicates no pain, 1 to 3 indicates mild pain, 4 to 6 indicates moderate pain and 7 to 9 indicates severe pain so that 10 indicates the worst possible pain | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of healing by the degree of healing through the classification: 0 for complete healing, 1 for healing of the surgical wound with the presence of a thin line of fibrin, 2 for healing of the surgical wound with the presence of fibrin, 3 for incomplete wound closure and dehiscence, 4 for unclosed wounds and presence of necrosis;Improvement of quality of life by the 14-item Oral Health Impact Profile questionnaire (OHIP-14). The patient's quality of life will be assessed using the which is composed of questions related to personal well-being, functional factors, pain experiences and physical, psychological and social discomfort. The OHIP-14 response format is: Always = 4; Often = 3; Almost always = 2; Sometimes = 1; Never = 0. The impact on quality of life is interpreted by the sum of the scores of the 14 questions, ranging from 0 to 56 points;Verify implant stability verified by the Osstell® Beacon device which uses the ISQ (implant stability quotient) parameter to determine stability. When the quotient is less than 60, low stability is identified. When the quotient is 60 to 69, medium stability is identified. If the quotient is greater than 70, high stability is identified | — |
Countries
Brazil
Contacts
Public ContactDaniel Pucca
Pontifícia Universidade Católica de Campinas
Outcome results
None listed